Transaction DateRecipientSharesTypePriceValue
2nd October 2020Advisors Llc Orbimed200,000Open or private purchase$25.00$5,000,000.00
2nd October 2020Advisors Llc Orbimed296,000Open or private purchase$25.00$7,400,000.00
1st October 2020Advisors Llc Orbimed296,296Open or private purchase$6.00$1,777,776.00
1st October 2020Advisors Llc Orbimed46,784,775Grant/award etc.$1.07$50,059,709.25
1st October 2020Advisors Llc Orbimed545,974Open or private purchase$6.00$3,275,844.00
1st October 2020Advisors Llc Orbimed639,212Open or private purchase$6.00$3,835,272.00
1st October 2020Advisors Llc Orbimed11,969,619Grant/award etc.$1.07$12,807,492.33
29th September 2020Advisors Llc Orbimed3,600,847Conversion of derivative$0.00
29th September 2020Advisors Llc Orbimed8,332,779Conversion of derivative$0.00
29th September 2020Advisors Llc Orbimed114,039Conversion of derivative$0.00
Principia Biopharma
Principia Biopharma logo

Principia Biopharma, Inc. is a biopharmaceutical company. It engages in design and development oral therapies to patients with significant unmet medical needs in immunology and oncology. The company was founded by Jack Taunton and Richard A. Miller on October 28, 2008.

Ticker: PRNB
Sector: Health Technology
Industry: Pharmaceuticals: Major
SEC Central Index Key (CIK): 1510487
Employees: 103
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags